Yao-Cheng (Leo) Li

Yao-Cheng (Leo) Li has a strong background in biopharmaceutical and biological research. Yao-Cheng (Leo) is currently a Principal Scientist at Protego Biopharma, where they began working in August 2022. Prior to this role, Leo served as a Senior Scientist at Trutino Biosciences from March 2022 to July 2022. Leo's extensive experience also includes working at the Salk Institute for Biological Studies for nearly two decades. Yao-Cheng (Leo) held various roles at the institute, starting as a Research Associate from June 2003 to October 2009, then advancing to the position of Senior Research Associate from November 2009 to April 2013. Finally, Leo served as a Scientist at the Salk Institute from May 2013 to February 2022. Overall, Leo's work experience demonstrates their expertise and commitment to scientific research in the biopharmaceutical and biological fields.

Yao-Cheng (Leo) Li's education history starts with their Bachelor's degree in Plant Pathology/Phytopathology, which they obtained from National Chung Hsing University from 1988 to 1992. Yao-Cheng (Leo) then pursued a Master's degree in Biochemistry from National Yang Ming University, attending from 1992 to 1994. Following this, they enrolled in Rutgers University and Rutgers Robert Wood Johnson Medical School, where they earned a Doctor of Philosophy (PhD) degree in Cellular and Molecular Pharmacology, a program they completed from 1996 to 2002.